Epineuron Receives FDA 510(k) Clearance for Evala® Nerve Stimulator

Evolution in intraoperative nerve identification and evaluation. MISSISSAUGA, Ontario — Epineuron, a medical device company pioneering bioelectronic medicine, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Evala® Nerve Stimulator. This handheld, intraoperative electrical stimulation device is engineered to provide surgeons with a rapid and accurate solution for... The post Epineuron Receives FDA 510(k) Clearance for Evala® Nerve Stimulator appeared first on Montreal Gazette .

Original source: Montreal Gazette